Retraction notice to "Clinical and metabolic response to probiotic administration in people with Parkinson's disease: A randomized, double-blind, placebo-controlled trial" [Clin Nutr 38 (2019) 1031-1035]
- PMID: 40820072
- DOI: 10.1016/j.clnu.2025.08.012
Retraction notice to "Clinical and metabolic response to probiotic administration in people with Parkinson's disease: A randomized, double-blind, placebo-controlled trial" [Clin Nutr 38 (2019) 1031-1035]
Retraction of
-
Clinical and metabolic response to probiotic administration in people with Parkinson's disease: A randomized, double-blind, placebo-controlled trial.Clin Nutr. 2019 Jun;38(3):1031-1035. doi: 10.1016/j.clnu.2018.05.018. Epub 2018 Jun 1. Clin Nutr. 2019. Retraction in: Clin Nutr. 2025 Aug 16:S0261-5614(25)00226-2. doi: 10.1016/j.clnu.2025.08.012. PMID: 29891223 Retracted. Clinical Trial.
Similar articles
-
Retraction notice to "Clinical and metabolic response to probiotic supplementation in patients with multiple sclerosis: A randomized, double-blind, placebo-controlled trial" [Clin Nutr 36 (2017) 1245-1249].Clin Nutr. 2025 Aug 14:S0261-5614(25)00225-0. doi: 10.1016/j.clnu.2025.08.011. Online ahead of print. Clin Nutr. 2025. PMID: 40816941 No abstract available.
-
Retraction notice to "The effects of probiotic and selenium co-supplementation on mental health parameters and metabolic profiles in type 2 diabetic patients with coronary heart disease: A randomized, double-blind, placebo-controlled trial" [Clin Nutr 38 (2019) 1594-1598].Clin Nutr. 2025 Aug 19:S0261-5614(25)00229-8. doi: 10.1016/j.clnu.2025.08.015. Online ahead of print. Clin Nutr. 2025. PMID: 40835487 No abstract available.
-
Clinical and metabolic response to probiotic administration in people with Parkinson's disease: A randomized, double-blind, placebo-controlled trial.Clin Nutr. 2019 Jun;38(3):1031-1035. doi: 10.1016/j.clnu.2018.05.018. Epub 2018 Jun 1. Clin Nutr. 2019. Retraction in: Clin Nutr. 2025 Aug 16:S0261-5614(25)00226-2. doi: 10.1016/j.clnu.2025.08.012. PMID: 29891223 Retracted. Clinical Trial.
-
Amantadine in Parkinson's disease.Cochrane Database Syst Rev. 2003;2003(1):CD003468. doi: 10.1002/14651858.CD003468. Cochrane Database Syst Rev. 2003. PMID: 12535476 Free PMC article.
-
Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease.Cochrane Database Syst Rev. 2012 Mar 14;2012(3):CD006504. doi: 10.1002/14651858.CD006504.pub2. Cochrane Database Syst Rev. 2012. PMID: 22419314 Free PMC article.
References
Publication types
LinkOut - more resources
Full Text Sources